0001140361-15-002061.txt : 20150116
0001140361-15-002061.hdr.sgml : 20150116
20150116202007
ACCESSION NUMBER: 0001140361-15-002061
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150115
FILED AS OF DATE: 20150116
DATE AS OF CHANGE: 20150116
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SANGAMO BIOSCIENCES INC
CENTRAL INDEX KEY: 0001001233
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 680359556
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 501 CANAL BLVD
STREET 2: POINT RICHMOND TECH CNTR.
CITY: RICHMOND
STATE: CA
ZIP: 94804
BUSINESS PHONE: 5109706000
MAIL ADDRESS:
STREET 1: 501 CANAL BLVD
STREET 2: POINT RICHMOND TECH CNTR.
CITY: RICHMOND
STATE: CA
ZIP: 94804
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LANPHIER EDWARD O II
CENTRAL INDEX KEY: 0001234386
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30171
FILM NUMBER: 15533744
MAIL ADDRESS:
STREET 1: C/O SANGAMO BIOSCIENCES IN STE.A-100
STREET 2: POINT RICHMOND TECH CENTER 501 CANA BLVD
CITY: RICHMOND
STATE: CA
ZIP: 94804
4
1
doc1.xml
FORM 4
X0306
4
2015-01-15
0
0001001233
SANGAMO BIOSCIENCES INC
SGMO
0001234386
LANPHIER EDWARD O II
C/O SANGAMO BIOSCIENCES INC.
POINT RICHMOND TECH CNTR, 501 CANAL BLVD
RICHMOND
CA
94804
1
1
0
0
President & CEO
Common Stock
2015-01-15
4
M
0
15000
6.82
A
250000
D
Common Stock
2015-01-15
4
S
0
13400
14.0912
D
236600
D
Common Stock
2015-01-15
4
S
0
1600
14.9666
D
235000
D
Common Stock
2015-01-16
4
M
0
10000
6.82
D
245000
D
Common Stock
2015-01-16
4
S
0
10000
14.2853
D
235000
D
Common Stock
1189021
I
By Trust
Employee Stock Option (Right to Buy)
6.82
2015-01-15
4
M
0
15000
0
D
2016-12-12
Common Stock
15000
185000
D
Employee Stock Option (Right to Buy)
6.82
2015-01-16
4
M
0
10000
0
D
2016-12-12
Common Stock
10000
175000
D
Includes 60,000, 50,000 shares and 125,000 subject to RSUs granted on December 6, 2012, December 12, 2013 and December 11, 2014, respectively, that will be issued as such units vest in accordance with their terms.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 20, 2014.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.60 to $14.54, inclusive. The Reporting Person undertakes to provide to Sangamo BioSciences, Inc., any security holder of Sangamo BioSciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.65 to $15.095, inclusive. The Reporting Person undertakes to provide to Sangamo BioSciences, Inc., any security holder of Sangamo BioSciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.90 to $14.57, inclusive. The Reporting Person undertakes to provide to Sangamo BioSciences, Inc., any security holder of Sangamo BioSciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
These shares are held in the Edward O. Lanphier II and Cameron M. Lanphier Trust U/T/A August 30, 2002, Edward O. Lanphier II and Cameron M. Lanphier, Trustees.
All shares underlying these options are vested and exercisable immediately.
/s/ Florence Tam, attorney-in-fact
2015-01-16